NightHawk Biosciences, Inc.


0.38 (USD) • At close November 27, 2023
Bedrijfsnaam NightHawk Biosciences, Inc.
Symbool NHWK
Munteenheid USD
Prijs 0.442
Beurswaarde 11,517,767
Dividendpercentage 0%
52-weken bereik 0.36 - 1.52
Industrie Biotechnology
Sector Healthcare
CEO Mr. Jeffrey Alan Wolf J.D.

An error occurred while fetching data.

Over NightHawk Biosciences, Inc.

NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator

Vergelijkbare Aandelen

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)